banner

Wall Street Cruises Higher as Data Comforts Investors

Weekly Jobless Claims

In New York, stocks moved solidly higher Thursday as positive domestic economic data comforted investors nervous about Greece’s ability to secure a second bailout.

The Dow Jones Industrials gained 123.13 points, or 1% to end the session at 12,904.10

The S&P 500 gathered 14.67 points to 1,357.90, while the tech-focused Nasdaq accelerated 44.02 points to 2,959.85

Both unemployment figures and housing numbers released ahead of the market’s open continue to paint a picture of a U.S. economy on the verge of a comeback.

Such economic numbers helped investors look beyond more negative signs from Europe. Moody’s put 17 global banks and 114 European financial institutions on review for possible downgrades.

Nine of the global banks put on review by Moody’s are headquartered in Europe, the agency said.



Moody’s added that Swiss banks Credit Suisse and UBS, as well as New York-based Morgan Stanley, could see their long-term ratings slashed by up to three notches.

U.S.-based Citigroup, Goldman Sachs, JPMorgan Chase and Bank of America were also put on watch. By afternoon trading, these banks moved up more than 1%, after initially falling by more than 1%.

General Motors posted a record $7.6-billion U.S. net profit for 2011, making it the first year since 2004 that all Big Three automakers — GM, Ford and Chrysler — were profitable.

DirectTV beat earnings and sales estimates during the fourth quarter, with particular strength coming from the company’s presence in Latin America. DirectTV also announced a $6-billion U.S. stock buyback program.

Nvidia’s stock tumbled a day after the company first-quarter revenue forecast fell short of Wall Street’s estimate.

Shares of J.M. Smucker slid after the maker of Jif peanut butter and Folgers coffee posted a 11% drop in its fiscal third-quarter profit that was also below expectations.

Shares of Amazon were down after Apple asked the e-commerce company to halt sales of the iPad in China. The move came after Apple lost a trademark dispute over the “iPad” name in Chinese courts.

Meanwhile, uncertainty remains over Greece and its efforts to secure much-needed additional bailout funds. European finance ministers delayed a decision on the bailout Wednesday, as they continue to evaluate a proposed austerity program from Athens.

The Eurogroup meets again Monday and indicated it would likely give its approval for the latest economic reform proposal, which Greece needs in order to secure bailout funds and avoid defaulting on a 14.5-billion euro bond redemption in March.

On the economic ledger, initial unemployment claims for the week ended February 11 fell to 348,000 — down 13,000 from the week prior, the U.S. Labor Department said.

Economists were expecting 365,000 claims, according to consensus estimates from Briefing.com.

Housing starts for January rose 1.5% to 699,000, according to the Commerce Department. Building permits rose 0.7% to 676,000 in January. Both totals were higher than expected.

Wholesale inflation, in the form of the Producer Price Index for January, rose 0.1%, following a decline of 0.3% the month prior. The index was expected to have increased by 0.3% last month.

Treasury prices for the 10-year note lost ground, lifting yields to 1.99% from Wednesday’s 1.93%. Treasury prices and yields move in opposite directions.

Oil for February delivery gained 36 cents to $102.28 U.S. a barrel.

Gold futures for April delivery moved up five cents to $1,726.80 U.S. an ounce

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Markets Take Another Pounding

Markets Take Another Pounding(0)

U.S. stocks were lower for a fifth day Thursday, as investors continued to fret about Greece”s future in the euro-zone. The Dow Jones Industrials closed down 156.06 points, or 1.2%, to 12,442.50 The S&P 500 demurred 19.94 points to 1,304.86. The tech-rich Nasdaq Composite Index capsized 60.35 to 2,813.69. Retail giants Wal-Mart and Sears Holdings

Winning Brands Gets First Order from Canada

Winning Brands Gets First Order from Canada(0)

Winning Brands Corporation (Pink Sheets: WNBD) reported that it has received its first order for delivery of 1000+™ Stain Remover, World’s Most Versatile Cleaning Solution™, to a military facility, in Canada.  1000+ is manufactured by the Niagara Mist Marketing Division of Winning Brands.  The first order is for product to be used at a Canadian

Premiere Opportunities Partners with Flex Fuel Technologies

Premiere Opportunities Partners with Flex Fuel Technologies(0)

Totowa, New Jersey-based Premiere Opportunities Group, Inc. (OTCQB: PPBL) has signed an advisory agreement with Flex Fuel Technologies Inc. to assist the company with its strategic planning, EPA testing and budget planning for the future introduction of its products into the automotive aftermarket. Flex Fuel Technologies, Inc. has developed a ” bolt on technology,” called

Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology

Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0)

Every industry or sector has pioneers that worked at the forefront of the field to shepherd new technologies into the mainstream. Oncology, for example, took huge steps forward as a result of the efforts of Dr. Sidney Farber, earning him the titles of “the father of the modern era of chemotherapy” and “father of modern

Overhyped Social Media Stocks Highlight Value in CrowdGather

Overhyped Social Media Stocks Highlight Value in CrowdGather(0)

There is a lot of activity surrounding social media stocks with the Initial Public Offering of Facebook (NASDAQ: FB) coming on Friday.  The new listing, which could see the company valued at as much as $100 billion, has investors and analysts already concerned that the world’s largest social network could be overvalued from the get-go. 

read more
banner


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.